23andMe is a personal genomics and biotechnology company.

Founded in 2006, 23andMe offers a proprietary FDA-approved genetic microarray test and web portal that helps consumers understand their health, genetic traits, and ancestry.  To date, the company has collected genotype data for approximately 3 million people.  Headquartered in Mountain View, California, 23andMe is also backed by GlaxoSmithKline, Fidelity, Sequoia Capital, and others.

For more information, please visit www.23andMe.com